With the emergence and long-term Impact of COVID-19, the Global Clostridium Diagnostics Market is to reach USD 1450.73 million by 2030
Bizwit Research & Consulting LLP’s Recent Analysis on Global Clostridium Diagnostics Market is poised to raise up to USD 1450.73 million by 2030. Clostridium is a gram-positive bacterium and is present in multiple species. The gastrointestinal disorder Clostridium Difficile Infection (CDI), which is brought on by this bacterium, also leads to diarrhoea brought on by antibiotics. The diagnosis of this illness is made using a variety of imaging methods, including radiography, CT, and endoscopy. Globally, the population is ageing significantly, and it is anticipated that the prevalence of clostridium-related illnesses would boost clostridium diagnostics market revenue.
Future lifestyle changes, continuous healthcare infrastructure development, and technology advancements such as artificial intelligence and automation are other factors that are projected to contribute to clostridium diagnostics market expansion. Robotics and automation are being used in clinical laboratories excessively, which benefits patients by enabling lab staff to deliver findings more swiftly and accurately.
Transport, categorization, accessory, and inspection of samples might all be automated with the help of modern diagnostic technology. For more than 10 years, laboratories’ reliance on automation to maintain profitability has increased demand for better clostridium testing. The rise in clostridium difficile infection (CDI) is poised to stimulate the need for diagnostic solutions, thereby fueling the growth of the global clostridium difficile diagnostics market. Notably, Cures, an open-access medical journal, reported in December 2021 that C. difficile infection affects 13 individuals per 1,000 worldwide, with approximately 75% of cases linked to hospitalization. This data underscores the escalating demand for diagnostics in response to the increasing prevalence of CDI.
Healthcare-Associated CDI (HA-CDI) rates have been related to higher rates of hospital admissions and antibiotic use. Increased morbidity and death have been associated with nosocomial CDI. Additionally, the development of cutting-edge diagnostic tools and rising public awareness of presymptomatic blood screening for infectious disorders expected to provide lucrative market growth opportunities over the forecast period. However, the high cost of Clostridium Diagnostics stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Clostridium Diagnostics Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market due to the nation’s widespread usage of antibiotics. Over the forecasted duration, the clostridium diagnostics market is expected to experience growth driven by the escalating incidence of clostridium-related disorders in the region.
The expansion of the American market can be attributed to heightened public awareness, thanks to concerted launch initiatives by various organizations. Notably, the “See C. diff” campaign launched by the Peggy Lillis Foundation in December 2020 successfully reached over 250,000 Americans, contributing to the market’s upward trajectory. Asia Pacific is expected to grow significantly over the forecast period, Because of rising healthcare expenses and clostridium prevalence, the growing economies in the Asia Pacific region, had lucrative growth over the forecast period.
The Japanese market is experiencing growth due to the implementation of impactful measures. Notably, in March 2022, Japan established a new institution with a budget of USD 1.6 million dedicated to supporting vaccine and pharmaceutical initiatives. This initiative is part of a broader strategy to address infectious diseases. The institution, known as SCARDA, will play a pivotal role in managing funds for research and development (R&D) projects and establishing a flagship R&D site for collaborative endeavors. These strategic components are expected to create multiple opportunities for expansion in the Japanese market throughout the projected period
The global Clostridium Diagnostics Market is highly competitive owing to the presence of several key manufacturers such as F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Merck & Co. Inc., Pfizer, Inc., Actelion Pharmaceuticals U.S, Inc., Abbott Laboratories, Trinity Biotech Plc., and others.
For further analysis on this or to request a sample copy of this report, please click the link mentioned below:
Key findings of the study suggest:
- Global Clostridium Diagnostics Market is anticipated to grow with a healthy growth rate of more than 7.10 % over the forecast period 2023-2030.
- In the End User segment, hospitals emerged as the leading market segment in 2022.
- North America is anticipated to drive regional growth owing to escalating incidence of clostridium-related disorders.
- Asia Pacific is expected to grow at a high CAGR followed by North America during 2023-2030.
Bizwit Research & Consulting has considered the following segments for the study:
By Diagnostic Test:
- Enzyme Immunoassays
- Realtime Polymerase Chain Reaction (RT-PCR)
- Nucleic Amplification Tests (NAAT)
- Stool Test
- Blood Test
- Others
By End User:
- Hospitals
- Diagnostic Centers
- Specialty Clinics
- Others
Regional Outlook
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Korea
- Australia
- RoAPAC
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
To get a sample of this report or to purchase a copy of the study, you can directly contact us at: sales@bizwitresearch.com
About Us
Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. The company has a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. Bizwit incorporate big data, expert analysis, and huge industry database to deliver client focused business consulting reports. Our analysts perform unbiased measurement and assessment of market opportunities to comprehend detailed market forecast. Our team of key opinion leaders evaluates the market size, growth prospects, end-use, applications, value & supply chain and top vendors in the industry to help the clients to take conversant business decisions without any vague assumptions.
Contact US
Global Business Development
Phone : +1 209 498-3066
Email: Sales@bizwitresearch.com
Website: www.bizwitresearch.com
